Kuwano K, Nomoto Y, Kunitake R, Hagimoto N, Matsuba T, Nakanishi Y, Hara N
Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, Higashiku, Fukuoka, Japan.
Eur Respir J. 1997 Jul;10(7):1445-9. doi: 10.1183/09031936.97.10071445.
The history of patients with idiopathic pulmonary fibrosis (IPF) shows that the disease may be preceded by a viral-like illness. Although viruses have not been demonstrated, it is possible that viruses were not detected in culture because they do not replicate during latency. We investigated the presence of adenovirus in IPF and interstitial pneumonia associated with collagen vascular disease (CVD-IP), using the nested polymerase chain reaction (PCR) and in situ hybridization (ISH) for the E1A region of the adenovirus genome. Studies were performed on lung tissues obtained by transbronchial lung biopsy from 19 patients with IPF, 10 patients with CVD-IP and, for comparison, from 20 patients with sarcoidosis. The E1A DNA was present in 3 out of 19 (16%) cases of IPF, in 5 of 10 (50%) cases of CVD-IP, and in 2 of 20 (10%) cases of sarcoidosis. The incidence of E1A DNA in CVD-IP was significantly higher than that in sarcoidosis (p<0.05). In patients with IPF and CVD-IP, E1A DNA was more prevalent in patients treated with corticosteroids (6 out of 9 cases; 67%) than in those without it (2 out of 20 cases; 10%) (p<0.01). ISH studies showed that 1 out of 8 cases of IPF and CVD-IP, in which E1A DNA was detected by PCR, was positive for E1A DNA. We conclude that adenovirus E1A is unlikely to be aetiologically involved in the pathogenesis of idiopathic pulmonary fibrosis or interstitial pneumonia associated with collagen vascular disease. However, a latent adenovirus infection may be reactivated or may newly infect the host following corticosteroid administration.
特发性肺纤维化(IPF)患者的病史显示,该疾病可能在类似病毒感染的疾病之后出现。尽管尚未证实病毒的存在,但有可能是因为病毒在潜伏期不复制,所以在培养中未被检测到。我们使用针对腺病毒基因组E1A区域的巢式聚合酶链反应(PCR)和原位杂交(ISH)技术,研究了腺病毒在IPF和与胶原血管疾病相关的间质性肺炎(CVD-IP)中的存在情况。对19例IPF患者、10例CVD-IP患者以及20例结节病患者经支气管肺活检获取的肺组织进行了研究。19例IPF病例中有3例(16%)存在E1A DNA,10例CVD-IP病例中有5例(50%)存在,20例结节病病例中有2例(10%)存在。CVD-IP中E1A DNA的发生率显著高于结节病(p<0.05)。在IPF和CVD-IP患者中,接受皮质类固醇治疗的患者E1A DNA更为普遍(9例中有6例;67%),而未接受治疗的患者中则较少(20例中有2例;10%)(p<0.01)。ISH研究显示,在8例经PCR检测到E1A DNA的IPF和CVD-IP病例中,有1例E1A DNA呈阳性。我们得出结论,腺病毒E1A不太可能在特发性肺纤维化或与胶原血管疾病相关的间质性肺炎的发病机制中起病因学作用。然而,潜在的腺病毒感染可能在皮质类固醇给药后被重新激活或可能新感染宿主。